The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.

Abstract

The subcutaneous administration of octreotide in acute pancreatitis of moderate severity might be of little benefit only at a dose of 200 micrograms t.i.d. or 300 micrograms t.i.d. for at least seven days.